Evidence map›Paper›PMID 23821545›Full record

ArticleThe Journal of biological chemistry2013

Activation of aryl hydrocarbon receptor (ahr) by tranilast, an anti-allergy drug, promotes miR-302 expression and cell reprogramming.

Wenxiang Hu, Jian Zhao, Gang Pei

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Aryl Hydrocarbon Receptor: From Homeostasis to Tumor Progression.Frontiers in cell and developmental biology · 2022
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Epigenetic Regulations of AhR in the Aspect of Immunomodulation.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Uricosuric targets of tranilast.Pharmacology research & perspectives · 2017
    Article
  16. Article
  17. Regulatory mechanisms of microRNA expression.Journal of translational medicine · 2016
    Review
  18. Article
  19. New Trends in Aryl Hydrocarbon Receptor Biology.Frontiers in cell and developmental biology · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Wenxiang HuState Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Graduate School of the Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Jian Zhao
Gang Pei
Chinese Academy of Sciences · CNShanghai Institutes for Biological Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MiR-302 has been shown to regulate pluripotency genes and help somatic cell reprogramming. Thus, promotion of endogenous miR-302 expression could be a desirable way to facilitate cell reprogramming. By using a luciferase reporter system of the miR-302 promoter, we screened and found that an anti-allergy drug, tranilast, could significantly promote miR-302 expression. Further experiments revealed that two aryl hydrocarbon receptor (AhR) binding motifs on the miR-302 promoter are critical and that activation of AhR is required for tranilast-induced miR-302 expression. Consistently, not only tranilast but other AhR agonists promoted miR-302 expression. Furthermore, the activation of AhR facilitated cell reprogramming in a miR-302-dependent way. These results elucidate that miR-302 expression can be regulated by AhR and thus provide a strategy for promoting somatic cell reprogramming by AhR ligands.

Indexed as

Promoter Regions, GeneticAmino Acid MotifsAnimalsAnti-Allergic AgentsBasic Helix-Loop-Helix ProteinsCell DedifferentiationCells, CulturedGene Expression RegulationMiceMicroRNAsortho-AminobenzoatesReceptors, Aryl HydrocarbonAhr protein, mouseAnti-Allergic AgentsBasic Helix-Loop-Helix ProteinsMicroRNAsMIRN302 microRNA, mouseortho-AminobenzoatesReceptors, Aryl HydrocarbontranilastAryl Hydrocarbon ReceptorInduced Pluripotent Stem (iPS) CellmicroRNAReprogrammingSmall MoleculesTranilast

Identifiers

PMID23821545
PMCPMC3753054
OpenAlexW2021891161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.